PharmTech

How to Achieve Different Release Profiles and Select Excipients for Formulation Development of Modified Release Oral Solid Dosage Forms

The art of modified release dosage forms is highly specialized. The approach that Societal™ takes is one of thoughtful planning and execution. Get the essential updates shaping the future of pharma ...
Medscape

Overview of Oral Modified-Release Opioid Products for the Management of Chronic Pain

Objective: To evaluate pharmaceutical and pharmacotherapeutic differences in oral opioid modified-release products used in the management of chronic pain. Data Sources: Searches of MEDLINE (1966-May ...
PharmTech

Combining Multiparticulates and 3DP for Patient-Centric Dosage Forms

Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery. Pharmaceutical manufacturers use a wide range of technologies, such as tablet coating, ...
Business Wire

Neos Therapeutics Resubmits New Drug Application for FDA Review of Amphetamine Extended-Release Orally Disintegrating Tablets to Treat ADHD

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (NASDAQ: NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (“XR”) product candidates for ...
Nasdaq

Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology

NEW YORK--(BUSINESS WIRE)-- Laxxon Medical Corp., a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced that Veru Inc. (NASDAQ ...